Anemia as a potent marker of in-hospital mortality in patients admitted to the cardiac intensive care unit: Data from the Critical Care Cardiology Trials Network (CCCTN) Registry.

In addition, the recent MINT trial of patients with anemia and ACS demonstrated a nonsignificant trend toward reduced risk of the composite outcome of recurrent ACS or death over 30 days in patients with a restrictive strategy (Hgb <7 g/dL or <8 g/dL cut-off) versus a liberal transfusion strategy (Hgb <10 g/dL cut-off) (RR=1.15, 95 % CI: 0.99 to 1.34, P =0.07) [ 25 , 26 ] .

also in 5,406 other papers